Life has many ups and downs, and it's normal to feel the lows from time to time. However, for some people, this sadness may ...

We’re used to hearing that depression is a chemical problem, one that starts in the brain and can only be fixed with ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

Older adults with major depression exhibit unique patterns of risky driving independent of antidepressant use, suggesting the need for targeted interventions to ensure safety.